Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk

TitleDiscovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk
Publication TypeJournal Article
Year of Publication2014
AuthorsZhao H., Caflisch A.
JournalBioorganic & Medicinal Chemistry Letters
Volume24
Issue6
Pagination1523-1527
Date Published2014 Mar 15
Type of ArticleResearch Article
ISSN1464-3405
KeywordsBinding Sites, Drug Evaluation, Preclinical, Humans, Intracellular Signaling Peptides and Proteins, Molecular Docking Simulation, Protein Binding, Protein Kinase Inhibitors, Protein Structure, Secondary, Protein Structure, Tertiary, Protein-Tyrosine Kinases, ZAP-70 Protein-Tyrosine Kinase
Abstract

The non-receptor tyrosine kinase Syk (spleen tyrosine kinase) is a pharmaceutical relevant target because its over-activation is observed in several autoimmune diseases, allergy, and asthma. Here we report the identification of two novel inhibitors of Syk by high-throughput docking into a rare C-helix-out conformation published recently. Interestingly, both compounds are slightly more active on ZAP70 (Zeta-chain-associated protein kinase 70), which is the kinase closest to Syk in the phylogenetic tree of human kinases. Taken together, the docking pose and experimental results suggest that the higher affinity of the inhibitors for ZAP70 than Syk originates from a more populated C-helix-out conformation in ZAP70. The latter observation is congruent with the 100-fold lower intrinsic activity of ZAP70 than Syk, as the C-helix-out conformation is inactive. The pharmacophore features of DFG-in, C-helix-out compounds are analyzed in relation to DFG-out inhibitors.

DOI10.1016/j.bmcl.2014.01.083
pubindex

0184

Alternate JournalBioorg. Med. Chem. Lett.
PubMed ID24569110